Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells

Kidney International

Volumn 80, Issue 7, 2011, Pages 731-739

  Zavaczki, Erzsébet ^a   Jeney, Viktória ^a,b   Agarwal, Anupam ^c   Zarjou, Abolfazl ^a,c   Oros, Melinda ^d   Katkó, Mónika ^a   Varga, Zsuzsa ^a   Balla, György ^a,d   Balla, József ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

cystathionine lyase; hydrogen sulfide; vascular calcification; vascular smooth muscle cell

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; OSTEOCALCIN; PHOSPHATE; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR RUNX2;

ADULT; ARTICLE; BLOOD LEVEL; CALCIFICATION; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE INDUCTION; HEMODIALYSIS; HUMAN; HUMAN CELL; MALE; MINERALIZATION; OSTEOBLASTIC DIFFERENTIATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 80052855735     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.212     Document Type: Article

References (57)

1. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000; 35: 1226-1237. (Pubitemid 30354431)
2. Rumberger JA, Simons DB, Fitzpatrick LA et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 1995; 92: 2157-2162.
3. Sangiorgi G, Rumberger JA, Severson A et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998; 31: 126-133. (Pubitemid 28064732)
4. Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. AJR Am J Roentgenol 1964; 92: 865-871.
5. Loecker TH, Schwartz RS, Cotta CW et al. Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J Am Coll Cardiol 1992; 19: 1167-1172.
6. Lehto S, Niskanen L, Suhonen M et al. Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulindependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 978-983. (Pubitemid 26266896)
7. Olson JC, Edmundowicz D, Becker DJ et al. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 2000; 49: 1571-1578.
8. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 1992; 86: 322-324.
9. Niskanen LK, Suhonen M, Siitonen O et al. Aortic and lower limb artery calcification in type 2 (noninsulin-dependent) diabetic patients and nondiabetic controlsubjects: a five year follow-up study. Atherosclerosis 1990; 84: 61-71. (Pubitemid 20267456)
10. Burke AP, Taylor A, Farb A et al. Coronary calcification: insights from sudden coronary death victims. Z Kardiol 2000; 89: 49-53.
11. Taylor AJ, Burke AP, O'Malley PG et al. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation 2000; 101: 1243-1248. (Pubitemid 30158610)
12. Gué rin AP, Blacher J, Pannier B et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992. (Pubitemid 32183805)
13. Blacher J, Gué rin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
14. London GM, Blacher J, Pannier B et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434-438. (Pubitemid 34225679)
15. Giachelli CM, Jono S, Shioi A et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis 2001; 38: 34-37.
16. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 43: 300-304.
17. Shioi A, Nishizawa Y, Jono S et al. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995; 15: 2003-2009.
18. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: 10-17.
19. Lomashvili KA, Cobbs S, Hennigar RA et al. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401. (Pubitemid 38679664)
20. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006; 98: 905-912.
21. Otto F, Thornell AP, Crompton T et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-771. (Pubitemid 27516179)
22. Giachelli CM, Steitz S, Jono S. Potential roles of bone matrix proteins in vascular calcification. Clin Calcium 1999; 9: 20-27.
23. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 2002; 16: 1792-1798. (Pubitemid 35340360)
24. Doeller JE, Isbell TS, Benavides G et al. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem 2005; 341: 40-51. (Pubitemid 40615718)
25. Olson KR. Is hydrogen sulfide a circulating 'gasotransmitter' in vertebrate blood? Biochim Biophys Acta 2009; 1787: 856-863.
26. Levitt MD, Abdel-Rehim MS, Furne J. Free and acid-labile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue. Antioxid Redox Signal 2011; 15: 373-378.
27. Erickson PF, Maxwell IH, Su LJ et al. Sequence of cDNA for rat cystathionine g-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem J 1990; 269: 335-340. (Pubitemid 20236021)
28. Zhao W, Zhang J, Lu Y et al. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20: 6008-6016. (Pubitemid 33049276)
29. Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 2006; 26: 154-161. (Pubitemid 44162501)
30. Elrod JW, Calvert JW, Morrison J et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104: 15560-15565. (Pubitemid 47502956)
31. Yang G, Sun X, Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J 2004; 18: 1782-1784. (Pubitemid 39561683)
32. Yang G, Wu L, Wang R. Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J 2006; 20: 553-555. (Pubitemid 46671247)
33. Du J, Hui Y, Cheung Y et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19: 75-80. (Pubitemid 38489034)
34. Jeong SO, Pae HO, Oh GS et al. Hydrogen sulphide potentiates interleukin-1-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 345: 938-944.
35. Jeney V, Komó di E, Nagy E et al. Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S). Free Radic Biol Med 2009; 46: 616-623.
36. Kamoun P, Belardinelli MC, Chabli A et al. Endogenous hydrogen sulphide overproduction in Down syndrome. Am J Med Genet 2003; 116: 310-311. (Pubitemid 36056753)
37. Perna AF, Luciano MG, Ingrosso D et al. Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant 2009; 24: 3756-3763.
38. Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004; 43: 1104-1108. (Pubitemid 38691507)
39. Hayden MR, Goldsmith DJ. Sodium thiosulfate: new hope for the treatment of calciphylaxis. Semin Dial 2010; 23: 258-262.
40. Sen U, Vacek TP, Hughes WM et al. Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation. Pharmacology 2008; 82: 201-213.
41. Wu SY, Pan CS, Geng B et al. Hydrogen sulphide ameliorates vascular calcification induced by vitamin D3 plus nicotine in rats. Acta Pharmacol Sin 2006; 27: 299-306. (Pubitemid 43357025)
42. Zarjou A, Jeney V, Arosio P et al. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol 2009; 20: 1254-1263.
43. Block GA. Prevalence and clinical consequences of elevated Ca2P product in hemodialysis patients. Clin Nephrol 2000; 54: 318-324.
44. Burke SK. Phosphate is a uremic toxin. J Ren Nutr 2008; 18: 27-32. (Pubitemid 350251824)
45. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218. (Pubitemid 39031360)
46. Giachelli CM. Ectopic calcification: gathering hard facts about soft tissue mineralization. Am J Pathol 1999; 154: 671-675. (Pubitemid 29122585)
47. Steitz SA, Speer MY, Curinga G et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001; 89: 1147-1154. (Pubitemid 34627872)
48. Geng B, Chang L, Pan C et al. Endogenous hydrogen sulphide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318: 756-763. (Pubitemid 38624219)
49. Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004; 313: 22-27. (Pubitemid 37524019)
50. Chunyu Z, Junbao D, Dingfang B et al. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-816.
51. Bian JS, Yong QC, Pan TT et al. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 2006; 316: 670-678.
52. Zhu YZ, Wang ZJ, Ho P et al. Hydrogen sulfide and its cardioprotective effects in myocardial ischemia in experimental rats. J Appl Physiol 2007; 102: 261-268. (Pubitemid 46089775)
53. Clarke M, Bennett M. The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol 2006; 26: 531-535. (Pubitemid 46143874)
54. Proudfoot D, Skepper JN, Hegyi L et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87: 1055-1062.
55. Proudfoot D, Davies JD, Skepper JN et al. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002; 106: 3044-3050. (Pubitemid 35440286)
56. Yang G, Wu L, Jiang B et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
57. Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J 1982; 206: 267-277.